Skip to main content

$0.925 0.030 (3.35%)

High

$0.93

Low

$0.90

Trades

28

Turnover

$33,271

Volume

36,561
30 June 2023 at 4:10pm
Register to track ARX and receive email alerts.

Myriad shown to be effective in surgical treatment of HS

StockBot

416,823 posts

ARX released this announcement to the ASX on 12 November 2020, 11:16. The announcement is not marked as price sensitive, and is 2 page(s) in length and 195.1kb in size.

You can view all announcements from ARX and see how they appear on a price chart on the announcements page.

At the date of this announcement, ARX was 0.000% short sold according to ASIC data. It was ranked the 619th most shorted stock on the ASX. It is now ranked as the 516th most shorted stock on the ASX with 0.035% of total shares short sold as of the latest reported data (26 May 2026).

Other Recent Announcements from ARX
Appendix 4G and Corporate Governance Statement 30 June 2023, 9:10
Annual Report to Shareholders 30 June 2023, 9:09
Notice of AGM Date and Director Nomination Closing Date 7 June 2023, 14:33
Investor Presentation 1 June 2023, 9:50
Myriad shown to be effective in surgical treatment of HS 12 November 2020, 11:16
Aroa to present at NWR Virtual Investor Conference 4 November 2020, 13:54
September Quarterly Report and Appendix 4C 27 October 2020, 10:28
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track ARX and receive email alerts.